METASTATIC COLON CANCER
Clinical trials for METASTATIC COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLON CANCER trials appear
Sign up with your email to follow new studies for METASTATIC COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New t cell engager takes on tough colorectal cancer
Disease control Recruiting nowThis early-phase trial tests a new drug called CBI-1214 in 80 people with advanced colorectal cancer that has not responded to standard treatments. CBI-1214 is designed to connect the body's own immune T cells to cancer cells, helping the immune system attack the tumor. The main …
Matched conditions: METASTATIC COLON CANCER
Phase: PHASE1 • Sponsor: Cartography Biosciences • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Blood test could catch colon Cancer's return before it starts
Disease control Recruiting nowThis study looks at whether a simple blood test can find tiny bits of cancer DNA left after surgery and chemotherapy for stage III colon cancer. If the test is positive, patients may get extra treatment with chemotherapy or immunotherapy to try to wipe out any remaining cancer ce…
Matched conditions: METASTATIC COLON CANCER
Phase: PHASE3 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New smart drug TQB6411 targets two cancer proteins in early human trial
Disease control Recruiting nowThis Phase 1 trial tests TQB6411, an antibody-drug conjugate designed to bind to EGFR and c-Met proteins on tumor cells, blocking their growth signals and releasing a toxin to kill the cells. The study will enroll 216 adults with advanced malignant tumors to find the safest dose …
Matched conditions: METASTATIC COLON CANCER
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Fiber fix: new supplement aims to stop Chemo-Induced diarrhea
Symptom relief Recruiting nowThis study tests a high-fiber product called NBT-NM108 in 42 people with advanced colon cancer who are receiving a chemotherapy drug called irinotecan. The goal is to see if the supplement can reduce or prevent the severe diarrhea that often comes with this treatment. By helping …
Matched conditions: METASTATIC COLON CANCER
Phase: PHASE2 • Sponsor: Howard S. Hochster, MD • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC